A synthetic peptide can repair cognitive decline, help treat early treatment of Alzheimer's



[ad_1]

WASHINGTON: Scientists have developed synthetic peptides that target and inhibit the formation of small, toxic proteins that trigger Alzheimer's disease.

The research, published in the Proceedings of the National Academy of Sciences, could help treat the neurodegenerative disorder at an early stage.

Alzheimer's disease is an aggregation disorder. Neurons in the human brain produce a protein called beta-amyloid. Such proteins, called beta-amyloid monomers, fulfill important tasks for neurons.

World Day of Parkinson's Disease: Coffee, Nuts and Fish Can Boost Brain Power

Stop cognitive decline early

April 11, 2019

Parkinson's disease, a neurodegenerative disease, affects the mobility and locomotion of the aging population.

Disabling disease occurs in the elderly (between the ages of 50 and 65) when brain cells are damaged. Dopamine, the brain's natural chemical, is responsible for communication between nerve cells. The disease develops when the brain is unable to produce dopamine and starts to abnormally store a protein called "Lewy body" in the dark substance, a part that controls the movement.

The symptoms of the disease – resting tremor, bradykinesia or slow movements, and muscular stiffness – develop gradually over the years. In most cases, the cause of the disease is not known.

On the occasion of World Parkinson's Day, here are some foods that can strengthen your cognitive abilities and help you get back on track.

However, in the brains of people with Alzheimer's disease, amyloid beta-monomers have dropped out of work and have regrouped.

First, they form oligomers – small mbades of a dozen proteins – then longer strands and finally large deposits called plates.

For years, scientists have thought that plaques cause the cognitive impairments characteristic of Alzheimer's disease. However, new research involves smaller aggregates of beta-amyloid as the toxic elements of this disease.

Researchers at the University of Washington in the United States have developed synthetic peptides (designed to integrate with a structure called alpha leaf) that can block beta-amyloid aggregation at the earliest and most toxic stage when the formation of oligomers.

brain memory_GettyImages

The team showed that blocking activity of the synthetic alpha leaf reduced the toxicity triggered by amyloid beta in cultured human neural cells and inhibited beta-oligomers of amyloid in two Animal laboratory models for Alzheimer's disease.

These findings add evidence to the growing consensus that amyloid beta-oligomers – and not plaques – are the toxic agents at the origin of Alzheimer's disease.

The results also indicate that synthetic alpha sheets could form the basis of the therapy to remove toxic oligomers in humans, according to Valerie Daggett, a professor at the University of Washington.

"It's about targeting a specific structure of beta-amyloid formed by toxic oligomers," said Daggett.

"What we have shown here, is that we can design and build synthetic alpha sheets with complementary structures to inhibit the aggregation and toxicity of the beta-amyloid substance, while leaving intact the biologically active monomers, "she said.

World No Tobacco Day: Smoking Can Hurts Eyes, Bones and Brain

Thrill Kills

May 31, 2018

Most smokers think that smoking is cool. No matter how you do it, tobacco is dangerous for your health. Tobacco contains more than 7,000 toxins and 70 known carcinogens (chemicals that increase the risk of cancer) and can damage almost every organ in the body.

Dr. Sachin Kumar, Senior Consultant in Respirology at Sakra World Hospital, explains how smoking affects all parts of your body.

The next time you are tempted to make an effort, stop just a minute and think about the consequences of your indulgence.

Peptides protected laboratory animals from damage by toxic oligomers. In mouse brain tissue samples, the team observed a fall in amyloid beta-oligomer levels of up to 82% after treatment with a synthetic alpha-peptide.

The administration of a synthetic alpha leaf to live mice caused a 40% fall in amyloid beta-oligomeric levels after 24 hours.

In the common laboratory worm Caenorhabditis elegans, another model for Alzheimer's disease, a treatment with synthetic alpha leaves delayed the onset of beta amyloid-induced paralysis.

The Daggett team continues its experiments with synthetic alpha sheets in order to develop even better compounds for the removal of amyloid beta-oligomers.

"What we are really looking for are potential treatments for beta-amyloid and diagnostic measures to detect toxic oligomers in humans," said Daggett.

Next Horizon of Science: AI to diagnose cerebral hemorrhage, spaceship for tra …

Tech Surprises

Sep 7, 2018

From the AI ​​who can diagnose a stroke to scientists who use antimatter for a truck ride, here is all that is exciting about the technologies that will shape our future. (Text: Rajarshi Bhattacharjee)

[ad_2]
Source link